Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Vaxgen, Inc
Department
Type
DUNS #
City
State
Country
Zip Code
Fay, Michael P; Follmann, Dean A; Lynn, Freyja et al. (2012) Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge. Sci Transl Med 4:151ra126
Margarit, Immaculada; Rinaudo, Cira Daniela; Galeotti, Cesira L et al. (2009) Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 199:108-15
Gorse, Geoffrey J; Keitel, Wendy; Keyserling, Harry et al. (2006) Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial. Vaccine 24:5950-9